Clinical trial
Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease
NCT02070484 is registered in ClinicalTrials.gov with OhioHealth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease
- Lead sponsor
- OhioHealth
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 28, 2014
- Completion date
- March 24, 2017
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bone diseases, intervertebral disk degeneration, intervertebral disk displacement, lumbar degenerative disc disease, musculoskeletal diseases, spinal diseases, spinal stenosis, spondylolisthesis, spondylolysis, spondylosis